Brands Build Ad Spending As Consumer Interest In Private Label Increases
This article was originally published in The Tan Sheet
Executive Summary
Increased ad spending to compete with both branded and private label products led to an average 4% profit margin slip since 2001 for the top 10 OTC drug makers, according to a report released by Kline & Co. Nov. 16